We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Novel Light-Based Technique With 90% Accuracy Rate to Revolutionize Cancer Diagnosis

By LabMedica International staff writers
Posted on 03 Sep 2024

A quicker, cheaper, and less painful cancer detection technique developed using light has the potential to revolutionize cancer diagnosis, early detection, and monitoring. More...

Researchers at Aston Institute of Photonic Technologies (AiPT, Birmingham, UK) have developed a new technique for analyzing crystals in dehydrated blood. Utilizing a novel polarization-based image reconstruction method, the team examined polycrystalline structures within dried blood samples. This analysis is vital as proteins in the blood undergo structural transformations in their tertiary (unique 3D shape) and quaternary forms (how multiple proteins assemble) during the onset of diseases such as cancer.

The new technique allows for a comprehensive layer-by-layer analysis of dry blood smears, a critical factor in distinguishing between healthy and cancerous samples. The research involved 108 blood film samples divided into three equal groups: healthy individuals, prostate cancer patients, and patients with aggressive cancer cells. The findings published in the Nature journal Scientific Reports showed a 90% accuracy rate in early diagnosis and classification of cancer, surpassing the efficacy of traditional screening methods. Moreover, this approach uses blood samples rather than tissue biopsies, making it a less invasive and safer option for patients.

"Our study introduces a pioneering technique to the liquid biopsy domain, aligning with the ongoing quest for non-invasive, reliable and efficient diagnostic methods,” said AiPT Professor Igor Meglinski. “A key advancement in our study is the characterization of the mean, variance, skewness, and kurtosis of distributions with the cells which is crucial for identifying significant differences between healthy and cancerous samples. This breakthrough opens new avenues for cancer diagnosis and monitoring, representing a substantial leap forward in personalized medicine and oncology."

Related Links:
AiPT


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.